OBESITY-INDUCED BY NEONATAL MONOSODIUM GLUTAMATE TREATMENT IN SPONTANEOUSLY HYPERTENSIVE RATS - AN ANIMAL-MODEL OF MULTIPLE RISK-FACTORS

Citation
M. Iwase et al., OBESITY-INDUCED BY NEONATAL MONOSODIUM GLUTAMATE TREATMENT IN SPONTANEOUSLY HYPERTENSIVE RATS - AN ANIMAL-MODEL OF MULTIPLE RISK-FACTORS, HYPERTENS R, 21(1), 1998, pp. 1-6
Citations number
28
Categorie Soggetti
Peripheal Vascular Diseas
Journal title
Hypertension research
ISSN journal
09169636 → ACNP
Volume
21
Issue
1
Year of publication
1998
Pages
1 - 6
Database
ISI
SICI code
0916-9636(1998)21:1<1:OBNMGT>2.0.ZU;2-M
Abstract
The present study was designed to develop an animal model of multiple risk factors, including obesity, hypertension, non-insulin-dependent d iabetes mellitus, and hyperlipidemia. Hypothalamic obesity was induced by neonatal monosodium glutamate (MSG) treatment in spontaneously hyp ertensive rats (SHR). Female newborn SHR were treated intraperitoneall y with 2 or 4 mg/kg body weight of MSG for 5 days. Obesity developed i n SHR treated with 4 mg/kg of MSG but not in SHR treated with 2 mg/kg of MSG. Obese SHR had impaired glucose tolerance, hyperinsulinemia, an d hypertriglyceridemia. However, the severity of hypertension was atte nuated in obese SHR as compared with control SHR. The degree of obesit y was closely related to the metabolic abnormalities, but inversely co rrelated with the blood pressure level. Macrovascular changes were inv estigated in obese SHR at 14 months of age. Intimal thickening was acc elerated in the carotid artery of obese SHR as compared with that of n onobese SHR. Aortic contents of DNA and total cholesterol were signifi cantly increased in obese SHR. SHR associated with MSG-induced obesity showed major manifestations of metabolic syndrome X. This animal mode l may be useful to study the clustering of risk factors for the develo pment of macrovascular diseases.